Yana Pikman

27PUBLICATIONS
215CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGene and molecular therapyHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 17, 2026
Allogeneic HSCT outcomes and impact of defibrotide prophylaxis on SOS after inotuzumab in pediatric B-ALL.

|May 26, 2026
A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.

|May 05, 2026
Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

|Apr 07, 2026
DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.

Lonneke Verboon, Sonali P Barwe, Meredith Tavenner

|Jan 08, 2026
Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemia.

Fanny Gonzales, Constanze Schneider, Gabriela Alexe

|Nov 21, 2025
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia.

Caroline R M Wiggers, Eugene Y Cho, Merve Ozdemir

Pageof 5

Frequent Collaborators

9 joint publications

Kimberly Stegmaier

9 joint publications

Gabriela Alexe

4 joint publications

Charlie Hatton

3 joint publications

Elliot Stieglitz